SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000728889-17-000290
Filing Date
2017-02-14
Accepted
2017-02-14 11:14:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sagetherapeuticsinc.htm SC 13G 19776
  Complete submission text file 0000728889-17-000290.txt   21465
Mailing Address 225 LIBERTY STREET NEW YORK NY 10281-1008
Business Address 225 LIBERTY STREET NEW YORK NY 10281-1008 212-323-0200
OppenheimerFunds, Inc. (Filed by) CIK: 0000728889 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Subject) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88275 | Film No.: 17604510
SIC: 2834 Pharmaceutical Preparations